Table 3.
Differentially produced metabolites identified and confirmed by targeted approach.
| mz | rt | P-value | FC | ESI | Sample (vs. Control) | Metabolite |
|---|---|---|---|---|---|---|
| 255.0643 | 2.39 | 0.060 | 0.30 | + | GmMYB176-Si | Daidzein (in source fragment) |
| 271.0592 | 2.54 | 0.091 | 0.33 | + | GmMYB176-Si | Genistein (in source fragment) |
| 417.1167 | 2.39 | 0.074 | 0.31 | + | GmMYB176-Si | Daidzin |
| 433.1117 | 2.54 | 0.067 | 0.32 | + | GmMYB176-Si | Genistin |
| 257.0842 | 2.83 | 0.084 | 0.17 | + | GmMYB176-Si | Liquiritigenin |
| 285.0750 | 2.90 | 0.076 | 0.29 | + | GmMYB176-Si | Glycitein |
| 166.0858 | 2.02 | 0.032 | 0.13 | + | GmMYB176-Si | Phenylalanine |
| 339.2882 | 4.42 | 0.081 | 0.21 | + | GmMYB176-Si | Glyceollin |
| 255.0699 | 2.84 | 0.036 | 2.43 | - | GmMYB176-OE | Liquiritigenin |
mz, mass to charge ratio; rt, retention time; FC, fold change.